Search from website

Human IgG1-kappa antibody to SARS CoV-2 NP (clone 80E7)

 

Figure 1. Simply Blue Safe Stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 80E7. 4-15% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 80E7 (+DTT). Line 2. Size marker. Line 3. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 80E7 (-DTT).

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

       

Figure 3. Octet RED96e analysis, antibody was loaded on sensor for capture of different concentrations of Nucleocapsid protein (200, 100, 50, 25 and 12.5 nM).

Select volume:

Quantity:

Catalogue #

R1-178-100

Name

Human IgG1-kappa antibody to SARS CoV-2 NP (clone 80E7)

Target

Nucleocapsid protein SARS-CoV-2

Target Description

Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line

Clonality

Human monoclonal

Clone

80E7

Class

hIgG1

Reactivity

SARS-CoV-2 Nucleocapsid protein

Dissociation constant (KD)

< 1.0 x 10-12 M

Application

ELISA

Kd:

<1.0 x 10-12 M

ELISA:

indirect ELISA 0,002-0,005 ng/ml

Purification

Protein A affinity chromatography following desalting

Buffer

PBS pH 7.4

Shipping

Shipped at ambient temperature.

Storage

Store at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart